ACHQC at AHS

QC Sessions at the Americas Hernia Society Annual Meeting

September 12-14, 2024

September 14-16, 2022

Updates on Embedded RCTs in the ACHQC

The ACHQC continues to partner closely with the American Hernia Society (AHS) for the benefit of patients, surgeons, hospitals, and industry partners.  This past September, the yearly ACHQC session at the 2022 AHS Annual Meeting focused on registry-embedded randomized controlled trials.  The session in Charlotte was well attended and summarized the groundbreaking efforts of the ACHQC to answer key clinical questions using the highest level of evidence.

Dr. Wes Love (Prisma Health, Greenville, SC) kicked off the session with results from the long anticipated Open versus Robotic Retromuscular Hernia Repair (ORREO) trial.  In this study, 91 (45 open, 46 robotic) patients were randomized to undergo either open or robotic-assisted retromuscular hernia repair.  No difference was observed in the primary composite outcome of short term wound morbidity, complications, and length of stay.  A 1-day reduction in length of stay was observed for the robotic-assisted approach.  Dr. Clayton Petro (Cleveland Clinic, Cleveland, OH) presented results of a randomized controlled trial comparing robotic IPOM versus robotic ETEP for ventral hernia.  In this multi-center trial involving 100 patients, patients undergoing either approach had similar rates of postoperative pain, narcotic usage, and length of stay.  Dr. Love presented a second randomized controlled trial of 250 (125 in each group) patients, the Reducing Infection at Surgical Site with Antibiotic Irrigation During Ventral Hernia Repair (RINSE) trial, led by the Prisma group which found that antibiotic irrigation of mesh prior to implantation did not result in a reduction in short term wound complications.  Finally, Dr. Ajita Prabhu (Cleveland Clinic, Cleveland, OH), showed long-term results of a randomized controlled trial comparing fixation to no fixation for open retromuscular repair.  After analyzing results in 325 patients, their group found that no fixation was not inferior to fixation with respect to recurrence 1 year after repair.

These registry embedded randomized trials make performing these studies much more efficient and easier to implement.  As more trials are performed, the ACHQC is leading the way in ensuring surgeons and patients have high quality data to make clinical decisions.

Open Versus Robotic Retromuscular Hernia Repair. The ORREO Trial

Robotic IPOM Versus Robotic eTEP

Antibiotic Irrigation to Reduce Wound Morbidity. The RINSE Trial

Fixation Versus No Fixation for Open Retromuscular Hernia Repairs: Long Term Results

September 25-26, 2020

ACHQC AND WHAT IT MEANS TO YOU

 

ACHQC OPIOID TASK FORCE UPDATE: WHY CHANGE? WHY NOW?

 

HERQLES ASSESSMENT OF INDIVIDUAL COMPONENTS: A 5 YEAR AHSQC ANALYSIS

 

Randomized Controlled Trial of Heavy & Medium Weight Mesh In Open, Retromuscular Ventral Hernia Repair

 

The Efficacy of Liposomal Bupivacaine On Postoperative Pain Following Abdominal Wall Reconstruction

 

Proposing a Systematic Approach to Repairing Flank Hernias: A Single-Center Experience

 

RISK FACTORS FOR INCISIONAL HERNIA RECURRENCE AND SURGICAL SITE OCCURRENCE OR INFECTION IN THE ABDOMINAL TRANSPLANT POPULATION: AN AMERICAS HERNIA SOCIETY QUALITY COLLABORATIVE (AHSQC) ANALYSIS

 

The Utility of Botulinum Toxin A (BTA) in Abdominal Wall Reconstruction (AWR): A Retrospective Analysis of the Americas Hernia Society Quality Collaborative

 

Is there an ideal plane for mesh placement during incisional hernia repair? An analysis using the Americas Hernia Society Quality Collaborative

 

Results from Complex Abdominal Reconstruction at a Non-academic Institution can Favorably Compare to Major Academic Centers